'Vildagliptin '

Vildagliptin 
VILDIABATE  is an oral medication that belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. VILDIABATE  is primarily used in the management of type 2 diabetes mellitus. Here are some key points about VILDIABATE :
Mechanism of action: VILDIABATE  works by inhibiting the enzyme DPP-4, which is responsible for breaking down incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By inhibiting DPP-4, VILDIABATE  increases the levels of GLP-1 and GIP, which help regulate blood sugar levels by stimulating insulin release and reducing the production of glucagon (a hormone that increases blood sugar levels).
Blood sugar control: VILDIABATE  is used to help lower and control blood sugar levels in individuals with type 2 diabetes mellitus. It is typically prescribed in combination with other antidiabetic medications, such as metformin, sulfonylureas, or insulin, as part of a comprehensive treatment plan.
Dosage and administration: VILDIABATE  is usually taken orally in the form of tablets. The dosage and frequency of administration are determined by a healthcare professional based on individual factors, including the patient's blood sugar levels, response to treatment, and other medical conditions.
Efficacy and benefits: VILDIABATE  has been shown to effectively reduce blood sugar levels in individuals with type 2 diabetes mellitus. It can help improve glycemic control and contribute to overall diabetes management. VILDIABATE  is important to note that vildagliptin is not a substitute for lifestyle modifications such as a healthy diet, regular exercise, and weight management, which are key components of diabetes management.
Side effects and precautions: VILDIABATE is generally well-tolerated, but like any medication, it can have potential side effects. Common side effects may include headache, dizziness, gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), and respiratory tract infections. Rarely, it may cause severe allergic reactions or pancreatitis. VILDIABATE important to inform your healthcare provider about any existing medical conditions or medications you are taking, as some drug interactions or contraindications may apply.
Monitoring and follow-up: Regular monitoring of blood sugar levels and periodic follow-up with a healthcare professional are important to assess the effectiveness of VILDIABATE and make any necessary adjustments to the treatment plan.
VILDIABATE   is available in strengths of 50 and 100 mg.
For further information please contact:
info@sterispharma.com
order now:- https://www.sterisonline.com/product/vildiabate-50-133451